1. Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.
- Author
-
Garabedian MJ, Hansen WF, Gianferrari EA, Lain KY, Fragneto RY, Campbell CL, and Booth DC
- Subjects
- Adult, Cesarean Section, Repeat, Female, Humans, Patient Care Team, Pregnancy, Antihypertensive Agents therapeutic use, Epoprostenol therapeutic use, Hypertension, Pulmonary drug therapy, Pregnancy Complications, Cardiovascular drug therapy
- Abstract
Idiopathic pulmonary arterial hypertension is a rare condition associated with significant maternal mortality. We report the management of a 37-year-old multigravida with severe disease using epoprostenol, a multidisciplinary approach, and a planned delivery. Although the patient survived the pregnancy, her pulmonary function significantly worsened. Epoprostenol, a pulmonary vasodilator, should be considered when indicated during pregnancy. Neither fetal nor neonatal harm was identified.
- Published
- 2010
- Full Text
- View/download PDF